Chemours Faces Investor Lawsuit Over Opteon Refrigerant Sales in the US
3 days ago
Chemours faces a securities class action lawsuit alleging misrepresentation of Opteon refrigerant sales and financial guidance, causing excess inventory and a share price drop after its Q2 2026 report.
Show all 25 updates